About

Sentio Solutions develops biomarkers and digital therapeutics to change the way we diagnose, manage, and care for mental health. The company’s premier offering Feel combines its proprietary Feel Emotion Sensor with evidence-based techniques. Sentio Solutions is backed by top VC firms and has kicked-off deployments with large Health & Life insurers in the USA and Germany. Feel is involved in many active research projects in collaboration with top tier universities in Greece and USA.

Solution & Product

Half a billion people suffer from some sort of mental illness (WHO). The current paradigm of care lacks objective data and tools to measure, evaluate, assess mental ailments and provide direction towards the right resources. People with mental issues don’t receive adequate and timely access to support outside therapists’ offices and at the time of need. Sentio's premier offering, the Feel Program, is an end-to-end digital solution for mental health that combines proprietary emotion recognition technology, real-time, AI-driven interventions through the Feel app, evidence-based techniques and online sessions with qualified mental health professionals to provide data-driven, personalized support and help users build coping mechanisms. In light of the COVID-19 pandemic, we are also offering the Feel Relief Program, a new program offering immediate access to tailored and structured, online mental health care support, to help people navigate through the pandemic or other periods of personal difficulty, maintain their morale and productivity and build emotional resilience, while providing an effective way to triage people to higher levels of support, according to need.

Innovation & Scalability

We offer unique, personalized and human-centered solutions to help people receive immediate access to care, stay accountable and improve their emotional wellbeing and resilience. Feel Relief and Feel provide 24/7 access to mental health online material and tailored exercises to help people learn self-management techniques, coping mechanisms and gain extra knowledge of their emotions and thoughts, leading to better emotional habits. Our participants and their providers gain access to uniquely combined objective and contextual data that define an individual’s emotional state and patterns, AI-driven DTx and tailored telehealth sessions to provide unparalleled engagement and effectiveness at half the cost of traditional and digital solutions. Also, we analyze data from emotion logs, mood journals and physiological monitoring from our devices and emotion recognition technology to maximize effectiveness in a tailored way for each individual's needs, while providing an effective way to engage and triage people to higher levels of support, according to need. Finally, the pandemic heightened the demand for telehealth and access to mental support and brought to the surface another pre-existing problem-the therapists' shortage. Our offerings address the providers' needs and offer digitized services to improve clinical outcomes, leverage objective data and insights, inside and outside the clinical setting while improving efficiency, effectiveness and reach.

Traction & achievements

Our team has raised $8M and has grown to 37 members across 4 locations (Greece, US, Germany and China). Over 2019 and 2020, we conducted PoCs with paying customers, among which, a Blue health plan in the US, SCOR (the world's 4th largest reinsurance company) & Gothaer (one of their health-life insurance carriers) in Germany. We have partnered with a big pharma company, hospital system, employers & benefit marketplaces & will start a pilot with a biopharma company specializing in oncology. From an R&D perspective, we conduct research studies with prestigious universities and institutions like Harvard, University of California/Riverside, Aiginiteio University Hospital, SF State and Stanford University. Our commercial traction will continue in 2021 and we believe that the adoption of our programs can revolutionize the field and add value in industries like pharma, healthcare providers, payers & governmental institutions.

Team & Why Us

Sentio’s 37 member team has extensive experience in the healthcare industry. Our core members of R&D and Data Science have PhDs in Biomedical Engineering and have spent many years in research projects around healthcare development through the use of technology. Our commercial, product and project teams have worked for many years on developing and bringing to market, healthcare solutions, technologies and population health programs, in well-known healthcare/insurance companies in the US and Europe. Our Clinical Team has many years of academic and direct clinical experience and are experts in Cognitive Behavioral Therapy and Positive Psychology.

Funding Needs

We are currently seeking our next round of funding which will help us grow further.